Experimental treatments are now attempting to neutralize neurodegenerative diseases before symptoms ever appear

Experimental immunotherapies are targeting the toxic proteins associated with Amyotrophic Lateral Sclerosis years before symptoms manifest, shifting the focus of neurodegenerative medicine from palliative care to early-stage prevention.